Home › Funds › ADAR1 Capital Management, LLC › TEVA

ADAR1 Capital Management, LLC position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

ADAR1 Capital Management, LLC reported holding 276,348 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$10.9M, representing 0.60% of its reported portfolio and ranking #45 among its reported holdings. ADAR1 Capital Management, LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)276.35K sh
Reported value held$10.94M
Portfolio Weight0.60%
First reportedQ4 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's TEVA position evolved

ADAR1 Capital Management, LLC first disclosed a stake in TEVA in Q4 2023 at 111,326 shares (US$1.2M). The position peaked in Q3 2026 at 276,348 shares, worth US$10.9M. Across 12 filings, ADAR1 Capital Management, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 276,348 shares valued at US$10.9M — a reduction of -1,500 shares quarter over quarter.. Notable position changes include a 36% increase in Q4 2024 (shares fell 30% over the following quarter), a 257% increase in Q1 2025 (shares rose 9% over the following quarter), a 34% trim in Q2 2025 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 111.33K $1.16M New
Q1 2024 101.63K $1.43M Reduce
Q2 2024 103.12K $1.68M Add
Q3 2024 108.17K $1.95M Add
Q4 2024 146.67K $3.23M Add
Q1 2025 523.77K $8.05M Add
Q2 2025 345.88K $5.80M Reduce
Q3 2025 267.82K $5.41M Reduce
Q4 2025 235.97K $7.36M Reduce
Q1 2026 268.39K $8.08M Add
Q2 2026 277.85K $9.41M Add
Q3 2026 276.35K $10.94M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 48 other funds we track also report a position in TEVA — the largest reported positions include BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held TEVA?

ADAR1 Capital Management, LLC has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in TEVA?

As of Q3 2026, ADAR1 Capital Management, LLC holds 276.35K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $10.94M, representing 0.60% of its reported portfolio and ranking #45.

Has ADAR1 Capital Management, LLC been buying or selling TEVA?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC reduced its position in TEVA. The position peaked in Q3 2026 at 276.35K shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.